INTERVENCIÓN CORONARIA PERCUTÁNEA EN PERSPECTIVA.

Pablo Moreno Franco

Enviado octubre 12, 2024

Publicado 2026-04-06

Artículos de Investigación

Vol. 15 Núm. 2 (2002): Revista Médico Científica

INTERVENCIÓN CORONARIA PERCUTÁNEA EN PERSPECTIVA.

Pablo Moreno Franco⁺⁻

PDF

Citación:

DOI: ND

Publicado: 2026-04-06

Derechos de autor 2024 Revista médico científica

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

Resumen

Las Intervenciones Coronarias Percutáneas (ICP ) representan un importante avance tecnológico para el diagnóstico y tratamiento de pacientes con una variedad de enfermedades cardiovasculares. Ciertamente, se han convertido en un campo cada vez con más aplicaciones, aún cuando - como todo procedimiento - tienen sus limitaciones. A pesar de estar lejos de tener experiencia práctica en las intervenciones coronarias, hemos tenido la oportunidad de recibir información en conferencias, transmisiones de casos en vivo y artículos recientes de importantes autores en la materia. El tener acceso a esta información nos plantea la inquietud de mostrar nuestra impresión acerca de la actualidad y futuro de éstas técnicas. Centramos nuestra discusión en el uso actual, en términos de las consideraciones generales de las ICP, incluyendo el tratamiento de lesiones complejas y de pequeños vasos, implicaciones del stent y el futuro papel de los "coated-stents"; así como las aplicaciones en las ICP de la cirugía robótica para procesos endoscópicos complejos, facilitados por computadoras.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301:61-8.
American Heart Association. 2001 Heart and Stroke Statistical Update. 2001; Dallas, TX: American Heart Association.
Detre KM, Holmes DR Jr, Holubkov R, et al. Incidence and consequences of periprocedural occlusion: the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1990; 82:739-50.
Popma JJ. Featured Lecture of the Day: Interventions-2002 New Devices, New Trials and New Developments. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Buchbinder M. New Modalities for PCI. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Yeung A. Complications and Emergencies During PCI. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Waksman R, Ghazzal Z, Baim D, Steenkiste A, Yeh W, Detre K, King III S for the NACI investigators: Myocardial Infarction as a Complication or New Interventional Devices. Am J Cardiol 1996; 78:751-6.
Fischman DL, Leon MB, Baim DS, et al., for the Stent Restenosis Study Investigators. A Randomized Comparison of Coronary Stent Placement and Balloon Angioplasty Treatment of CAD. N Engl J Med 1994; 331:496-501.
Garratt KN. In-stent Restenosis. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Infusion prior to stenting trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am J Cardiol 1998, Mar-Apr.
Mehran R, Mintz GS, Popma JJ, et al. Mechanism of restenosis and redilatation within coronary stents: quantitative angiographic assessment. Am J Cardiol 1996; 76:618-22.
Ferguson J. Pharmacology for Vascular Intervention. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Sanborn T. Molecular Biology-Gene Therapy and Angiogenesis. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Nabel EG, Plautz GE, Nabel GJ. Gene Therapy and Restenosis. In: Schwartz RS, ed. Coronary Restenosis. Boston: Blackwell Scientific, 1993:279-93.
Wilensky R, Jean-Francois T, Shigenori I, et al. Heparin Infusion prior to Stenting Trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am J Cardiol 1998, Mar-Apr.
Marchena E. Small Vessel and Diffuse Disease. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Savage MP, Fischman DL, Rake R, et al. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent Restenosis Study (STRESS) Investigator. J Am Coll Cardiol 1998; 31:307-11.
Cohen MG, Kong DF, Warner JJ, et al. Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents. Am J Cardiol 2000; 85:446-50.
Doucet S, Schalij MJ, Mathy CMM. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation 2001; 104:2029-33.
Mack MJ. Future of cardiac surgery. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.
Mack MJ. Minimally Invasive and Robotic Surgery. JAMA 2001; 285:568-72.
Lincoff AM, Popma JJ, Ellis SG, et al. Percutaneous support devices for high-risk or complicated coronary angioplasty. J Am Coll Cardiol 1991; 17:770.

Palabras clave

PDF

Resumen visto - 2 veces
PDF descargado - 1

Licencia

Content Top

[1] Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301:61-8.

[2] American Heart Association. 2001 Heart and Stroke Statistical Update. 2001; Dallas, TX: American Heart Association.

[3] Detre KM, Holmes DR Jr, Holubkov R, et al. Incidence and consequences of periprocedural occlusion: the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1990; 82:739-50.

[4] Popma JJ. Featured Lecture of the Day: Interventions-2002 New Devices, New Trials and New Developments. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[5] Buchbinder M. New Modalities for PCI. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[6] Yeung A. Complications and Emergencies During PCI. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[7] Waksman R, Ghazzal Z, Baim D, Steenkiste A, Yeh W, Detre K, King III S for the NACI investigators: Myocardial Infarction as a Complication or New Interventional Devices. Am J Cardiol 1996; 78:751-6.

[8] Fischman DL, Leon MB, Baim DS, et al., for the Stent Restenosis Study Investigators. A Randomized Comparison of Coronary Stent Placement and Balloon Angioplasty Treatment of CAD. N Engl J Med 1994; 331:496-501.

[9] Garratt KN. In-stent Restenosis. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[10] Infusion prior to stenting trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am J Cardiol 1998, Mar-Apr.

[11] Mehran R, Mintz GS, Popma JJ, et al. Mechanism of restenosis and redilatation within coronary stents: quantitative angiographic assessment. Am J Cardiol 1996; 76:618-22.

[12] Ferguson J. Pharmacology for Vascular Intervention. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[13] Sanborn T. Molecular Biology-Gene Therapy and Angiogenesis. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[14] Nabel EG, Plautz GE, Nabel GJ. Gene Therapy and Restenosis. In: Schwartz RS, ed. Coronary Restenosis. Boston: Blackwell Scientific, 1993:279-93.

[15] Wilensky R, Jean-Francois T, Shigenori I, et al. Heparin Infusion prior to Stenting Trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am J Cardiol 1998, Mar-Apr.

[16] Marchena E. Small Vessel and Diffuse Disease. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[17] Savage MP, Fischman DL, Rake R, et al. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent Restenosis Study (STRESS) Investigator. J Am Coll Cardiol 1998; 31:307-11.

[18] Cohen MG, Kong DF, Warner JJ, et al. Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents. Am J Cardiol 2000; 85:446-50.

[19] Doucet S, Schalij MJ, Mathy CMM. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation 2001; 104:2029-33.

[20] Mack MJ. Future of cardiac surgery. Proceedings of the Lumen Vascular Interventional Symposium; 2002 February 7-9, Miami, FL, U.S.

[21] Mack MJ. Minimally Invasive and Robotic Surgery. JAMA 2001; 285:568-72.

[22] Lincoff AM, Popma JJ, Ellis SG, et al. Percutaneous support devices for high-risk or complicated coronary angioplasty. J Am Coll Cardiol 1991; 17:770.

Imagen de portada

Resumen

Descargas

Citas

Palabras clave

Licencia